337 related articles for article (PubMed ID: 38730681)
1. Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells.
Lee PWT; Koseki LR; Haitani T; Harada H; Kobayashi M
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730681
[TBL] [Abstract][Full Text] [Related]
2. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Strowitzki MJ; Cummins EP; Taylor CT
Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
[TBL] [Abstract][Full Text] [Related]
3. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
[TBL] [Abstract][Full Text] [Related]
5. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase.
Haitani T; Kobayashi M; Koyasu S; Akamatsu S; Suwa T; Onodera Y; Nam JM; Nguyen PTL; Menju T; Date H; Ogawa O; Harada H
Cancer Lett; 2022 Mar; 528():76-84. PubMed ID: 34973392
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.
Wu Y; Li Z; McDonough MA; Schofield CJ; Zhang X
J Med Chem; 2021 Jun; 64(11):7189-7209. PubMed ID: 34029087
[TBL] [Abstract][Full Text] [Related]
8. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases.
Bruegge K; Jelkmann W; Metzen E
Curr Med Chem; 2007; 14(17):1853-62. PubMed ID: 17627521
[TBL] [Abstract][Full Text] [Related]
9. Oxygen-sensing under the influence of nitric oxide.
Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
[TBL] [Abstract][Full Text] [Related]
10. Biochemistry of the hypoxia-inducible factor hydroxylases.
Fiorini G; Schofield CJ
Curr Opin Chem Biol; 2024 Apr; 79():102428. PubMed ID: 38330792
[TBL] [Abstract][Full Text] [Related]
11. Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O
Park H
Toxicol Res; 2008 Jun; 24(2):101-107. PubMed ID: 32038783
[TBL] [Abstract][Full Text] [Related]
12. The role of HIF prolyl hydroxylases in tumour growth.
Jokilehto T; Jaakkola PM
J Cell Mol Med; 2010 Apr; 14(4):758-70. PubMed ID: 20178464
[TBL] [Abstract][Full Text] [Related]
13. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
14. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Flashman E; Davies SL; Yeoh KK; Schofield CJ
Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.
Webb JD; Coleman ML; Pugh CW
Cell Mol Life Sci; 2009 Nov; 66(22):3539-54. PubMed ID: 19756382
[TBL] [Abstract][Full Text] [Related]
16. An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor.
Shirai Y; Chow CCT; Kambe G; Suwa T; Kobayashi M; Takahashi I; Harada H; Nam JM
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200019
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HIF: asparaginyl hydroxylation.
Peet D; Linke S
Novartis Found Symp; 2006; 272():37-49; discussion 49-53, 131-40. PubMed ID: 16686428
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α pathway: role, regulation and intervention for cancer therapy.
Masoud GN; Li W
Acta Pharm Sin B; 2015 Sep; 5(5):378-89. PubMed ID: 26579469
[TBL] [Abstract][Full Text] [Related]
19. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity.
Lancaster DE; McNeill LA; McDonough MA; Aplin RT; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
Biochem J; 2004 Nov; 383(Pt. 3):429-37. PubMed ID: 15239670
[TBL] [Abstract][Full Text] [Related]
20. Role of iron (II)-2-oxoglutarate-dependent dioxygenases in the generation of hypoxia-induced phosphatidic acid through HIF-1/2 and von Hippel-Lindau-independent mechanisms.
Martín-Puig S; Temes E; Olmos G; Jones DR; Aragonés J; Landázuri MO
J Biol Chem; 2004 Mar; 279(10):9504-11. PubMed ID: 14681229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
